Is Cibus, Inc. (CBUS) a Buy, Sell, or Hold?
NASDAQ : CBUS
Cibus, Inc.
$1.85 USD
-$0.23 (-11.06%)
- Volume
- 309.14K
- Average Volume
- 366.9K
- Market Capitalization
- $84.15M
- P/E Ratio
- -1.05
- Dividend Yield
- 0.00%
- Price Target
- $11.50
- Year High
- $4.19
- Year Low
- $1.09
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.37
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Craig Wichner |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | CBUS |
| CUSIP | 17166A101 |
| CIK | 0001705843 |
| Web | https://www.cibus.com |
| Phone | 858 450 0008 |
| Currency | USD |
| Employees | 118 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 7.78 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.37 |
| Quick Ratio | 2.37 |
| Cash Ratio | 2.17 |
Sales & Book Value
| Annual Sales | $3.64M |
| Price / Sales | 19.63 |
| Cash Flow | -0.08 |
| Price / Cash Flow | -1.66 |
| Price / Book | 34.00 |
Price Target and Rating
| Average Stock Price Forecast | $11.50 |
| High Stock Price Forecast | $12.50 |
| Low Stock Price Forecast | $10.50 |
| Forecast Upside/Downside | -83.91% |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 4 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$2.78 |
| Trailing P/E Ratio | -1.05 |
| PEG Ratio | -0.01 |
| P/E Growth | -0.01 |
| Net Income | -$127.08M |
| Net Margin | -2366.33% |
| Pretax Margin | -2426.43% |
| Return on Equity | -225.59% |
| Return on Assets | -31.28% |
Financials Score
| AltmanZ Score | -4.22 |
| Piotroski Score | 3.00 |
| Working Capital | 19.12M |
| Total Assets | 324.2M |
| Ebit | -67.8M |
| Market Cap | 88.25M |
| Total Liabilities | 288.72M |
Poll Results
About Cibus, Inc. (NASDAQ:CBUS) Stock
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California. ...
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
2026-06-17 08:05:00
Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years Under new EU rules, crops improved without adding foreign DNA will be treated like conventionally bred crops, validating the approach Cibus has developed for 25 years
2026-06-08 18:30:00
SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced key leadership changes pursuant to the Company's previously announced succession planning strategy. As part of this plan, Craig Wichner, a board member since November 2025, has been appointed as the Company's Chief Executive Officer. Peter Beetham, who has served as the Company's Interim Chief Executive Officer, will continue his role as the Company's President and Chief Operating Officer. Concurrently, both Mr. Wichner and Dr. Beetham resigned from the Cibus Board of Directors as part of this reorganization and plan.
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
2026-05-14 20:00:43
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
2026-05-14 18:50:23
Cibus (CBUS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.74 per share a year ago.
Cibus Q1 Earnings Call Highlights
2026-05-14 18:12:31
Cibus NASDAQ: CBUS reported first-quarter 2026 results and said it is advancing toward commercialization across its rice and sustainable ingredients programs, while also reducing expenses and extending its cash runway into late in the first quarter of 2027.
Cibus Reports First Quarter Financial Results and Provides Business Update
2026-05-14 16:05:00
SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March 31, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m.
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
2026-05-06 13:01:09
Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2026-05-04 07:00:00
Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market
Frequently Asked Questions
-
What is the current Cibus, Inc. (CBUS) stock price?
-
Cibus, Inc.(NASDAQ:CBUS) stock price is $1.85 in the last trading session. During the trading session, CBUS stock reached the peak price of $4.191 while $1.09 was the lowest point it dropped to. The percentage change in CBUS stock occurred in the recent session was --11.06% while the dollar amount for the price change in CBUS stock was -$0.23.
-
CBUS's industry and sector of operation?
-
The NASDAQ listed CBUS is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CBUS?
-
Peter Beetham | Co-Founder, President & COO
Craig Wichner | Chief Executive Officer
Jason Stokes | Chief Administrative Officer, General Counsel & Corporate Secretary
Rosa Cheuk Kim | Senior Vice President of Legal
Noel Sauer | Senior Vice President of Research -
How many employees does CBUS have?
-
Number of CBUS employees currently stands at 118. CBUS operates from 6455 Nancy Ridge Drive, San Diego, CA 92121, US.
-
Link for CBUS official website?
-
Official Website of CBUS is: https://www.cibus.com
-
How do I contact CBUS?
-
CBUS could be contacted at phone #858 450 0008 and can also be accessed through its website. CBUS operates from 6455 Nancy Ridge Drive, San Diego, CA 92121, US.
-
How many shares of CBUS are traded daily?
-
The average number of CBUS shares traded daily for last 3 months was 366.9K.
-
What is the market cap of CBUS currently?
-
The market value of CBUS currently stands at $84.15M with its latest stock price at $1.85